tradingkey.logo

ProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCP

ReutersJun 26, 2025 9:44 PM

- ProQR Therapeutics NV PRQR.O:

  • PROQR ANNOUNCES CTA SUBMISSION FOR PHASE 1 STUDY OF AX-0810 TARGETING NTCP

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI